Herd Immunity to Hepatitis B in the Russian Federation in 2017–2019
Authors:
- S. N. KuzinSKS. N. Kuzin
- T. A. SemenenkoTST. A. Semenenko
- V. V. KlushkinaVKV. V. Klushkina
- N. V. VlasenkoNVN. V. Vlasenko
- N. S. ChurilovaNCN. S. Churilova
- Ya. V. PanasyukYPYa. V. Panasyuk
- E. N. KudryavtsevaEKE. N. Kudryavtseva
- M. I. Korabel'NIkovaMKM. I. Korabel'NIkova
- D. V. DubodelovDDD. V. Dubodelov
- Z. S. RodionovaZRZ. S. Rodionova
- G. G. SolopovaGSG. G. Solopova
Open Access
- 10 May 2022
- journal article
- research article
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 21 (2) , 29-37
Abstract
Relevance. Hepatitis B is a global problem of global and Russian public health due to its high prevalence and the possibility of forming a chronic form of the disease with the development of cirrhosis and hepatocellular carcinoma. Aims. Assessment of the herd immunity to hepatitis B in the population of the Russian Federation in 2017‒2019.Materials and methods. The research was carried out at the Central Institute of Epidemiology within the framework of a large-scale program to assess herd immunity to hepatitis B in the population of the Russian Federation. The results of studies for the presence of anti-HBs in various subjects of the Russian Federation in 2017 to 2019, which were performed in accordance with MU 3.1.2943-11, were analyzed. Additionally, as a reference study in 2020, a survey of donors in Moscow (n = 427) was conducted for the presence of anti-HBs. Standard methods of descriptive statistics Microsoft Excel and STATISTICA 12.0 (StatSoft, USA) were used for statistical processing. The mean values were estimated taking into account the 95% confidence interval [95% CI] (according to the Klopper-Pearson method (exact method).Results. The average annual values of the proportion of persons with protective immunity against hepatitis B for 2017, 2018 and 2019 were 70.03%, 67.95% and 66.36%, respectively. Significant differences were revealed in the average values of the proportion of persons with a protective level of anti-HBs in the Federal Districts (FD): higher than the average Russian indicators were found in the Northwestern (74.2%), Southern (71.0%) and Far Eastern FD (70.7%). In 44 subjects of the Russian Federation during the observation period, the proportion of persons with protective immunity against hepatitis B was less than 60%.Conclusion. The necessity of optimizing the system of serological monitoring of post-vaccination immunity against hepatitis B is substantiated, which will increase the effectiveness of preventive measures nationwideKeywords
This publication has 8 references indexed in Scilit:
- Some results of studying the effectiveness of vaccination against hepatitis BJournal Infectology, 2020
- Assessment of population immunity to hepatitis B virus in the population of a large city in the european part of RussiaЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT, 2019
- SEROEPIDEMIOLOGY IN THE SURVEILLANCE OF VACCINE-PREVENTABLE DISEASESJournal of microbiology, epidemiology and immunobiology, 2018
- Epidemiological and Immunological Efficacy of Health Workers Vaccination against Hepatitis BEpidemiology and Vaccinal Prevention, 2017
- Influences of obesity on the immunogenicity of Hepatitis B vaccineHuman Vaccines & Immunotherapeutics, 2017
- Use of serological surveys to generate key insights into the changing global landscape of infectious diseaseThe Lancet, 2016
- Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccineWorld Journal of Hepatology, 2015
- The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseasesCanadian Medical Association Journal, 2011